Development of an in situ cell-type specific proteome analysis method using antibody-mediated biotinylation

Area of Science:

• Proteomics
• Cellular Biology
• Biotechnology

Background:

• Understanding cellular functions and disease pathogenesis requires decoding proteome changes.
• Conventional proteomic studies on tissue lumps hinder cell-type specific analysis.
• Existing cell-specific methods often require genetic modification or are labor-intensive.

Approach:

• Developed in situ cell-type specific proteome analysis (iCAB) combining immunohistochemistry (IHC) and biotin-tyramide signal amplification.
• Utilized antibody-mediated biotinylation to enrich proteins from specific cell types within intact tissues.
• Applied iCAB to mouse brain tissue for neuronal, astrocyte, and microglia proteome enrichment.

Key Points:

• Successfully enriched and identified proteomes from distinct cell types in mouse brain tissue.
• Identified ~8,400 proteins from enriched samples, revealing differential expressions specific to cell types.
• Demonstrated iCAB is not biased toward any subcellular compartment and applicable to various tissues.

Conclusions:

• iCAB offers a non-genetic, efficient method for cell-type specific proteome analysis.
• This technique facilitates large-scale studies and accelerates understanding of biological and pathological phenomena.
• Paves the way for routine use of cell-type specific proteome analysis in research.